Report Detail
Global Imatinib Drug Market Insights and Forecast to 2026
- RnM4114818 |
- 05 August, 2020 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Imatinib Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Imatinib Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Imatinib Drug market is segmented into
Tablets
Capsules
Segment by Application, the Imatinib Drug market is segmented into
Chronic myelogenous leukemia
Gastrointestinal stromal tumors
Others
Regional and Country-level Analysis
The Imatinib Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Imatinib Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Imatinib Drug Market Share Analysis
Imatinib Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Imatinib Drug business, the date to enter into the Imatinib Drug market, Imatinib Drug product introduction, recent developments, etc.
The major vendors covered:
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.
1 Study Coverage
- 1.1 Imatinib Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key Imatinib Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Imatinib Drug Market Size Growth Rate by Type
- 1.4.2 Tablets
- 1.4.3 Capsules
- 1.5 Market by Application
- 1.5.1 Global Imatinib Drug Market Size Growth Rate by Application
- 1.5.2 Chronic myelogenous leukemia
- 1.5.3 Gastrointestinal stromal tumors
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Imatinib Drug Market Size, Estimates and Forecasts
- 2.1.1 Global Imatinib Drug Revenue 2015-2026
- 2.1.2 Global Imatinib Drug Sales 2015-2026
- 2.2 Global Imatinib Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Imatinib Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Imatinib Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Imatinib Drug Competitor Landscape by Players
- 3.1 Imatinib Drug Sales by Manufacturers
- 3.1.1 Imatinib Drug Sales by Manufacturers (2015-2020)
- 3.1.2 Imatinib Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 Imatinib Drug Revenue by Manufacturers
- 3.2.1 Imatinib Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 Imatinib Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Imatinib Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Imatinib Drug Revenue in 2019
- 3.2.5 Global Imatinib Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Imatinib Drug Price by Manufacturers
- 3.4 Imatinib Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Imatinib Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Imatinib Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Imatinib Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Imatinib Drug Market Size by Type (2015-2020)
- 4.1.1 Global Imatinib Drug Sales by Type (2015-2020)
- 4.1.2 Global Imatinib Drug Revenue by Type (2015-2020)
- 4.1.3 Imatinib Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Imatinib Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Imatinib Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global Imatinib Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 Imatinib Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Imatinib Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Imatinib Drug Market Size by Application (2015-2020)
- 5.1.1 Global Imatinib Drug Sales by Application (2015-2020)
- 5.1.2 Global Imatinib Drug Revenue by Application (2015-2020)
- 5.1.3 Imatinib Drug Price by Application (2015-2020)
- 5.2 Imatinib Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Imatinib Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global Imatinib Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Imatinib Drug Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Imatinib Drug by Country
- 6.1.1 North America Imatinib Drug Sales by Country
- 6.1.2 North America Imatinib Drug Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Imatinib Drug Market Facts & Figures by Type
- 6.3 North America Imatinib Drug Market Facts & Figures by Application
7 Europe
- 7.1 Europe Imatinib Drug by Country
- 7.1.1 Europe Imatinib Drug Sales by Country
- 7.1.2 Europe Imatinib Drug Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Imatinib Drug Market Facts & Figures by Type
- 7.3 Europe Imatinib Drug Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Imatinib Drug by Region
- 8.1.1 Asia Pacific Imatinib Drug Sales by Region
- 8.1.2 Asia Pacific Imatinib Drug Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Imatinib Drug Market Facts & Figures by Type
- 8.3 Asia Pacific Imatinib Drug Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Imatinib Drug by Country
- 9.1.1 Latin America Imatinib Drug Sales by Country
- 9.1.2 Latin America Imatinib Drug Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Imatinib Drug Market Facts & Figures by Type
- 9.3 Central & South America Imatinib Drug Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Imatinib Drug by Country
- 10.1.1 Middle East and Africa Imatinib Drug Sales by Country
- 10.1.2 Middle East and Africa Imatinib Drug Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Imatinib Drug Market Facts & Figures by Type
- 10.3 Middle East and Africa Imatinib Drug Market Facts & Figures by Application
11 Company Profiles
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description and Business Overview
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Imatinib Drug Products Offered
- 11.1.5 Novartis Related Developments
- 11.2 Glenmark Pharmaceuticals Ltd.
- 11.2.1 Glenmark Pharmaceuticals Ltd. Corporation Information
- 11.2.2 Glenmark Pharmaceuticals Ltd. Description and Business Overview
- 11.2.3 Glenmark Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Products Offered
- 11.2.5 Glenmark Pharmaceuticals Ltd. Related Developments
- 11.3 Sun Pharmaceuticals
- 11.3.1 Sun Pharmaceuticals Corporation Information
- 11.3.2 Sun Pharmaceuticals Description and Business Overview
- 11.3.3 Sun Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Sun Pharmaceuticals Imatinib Drug Products Offered
- 11.3.5 Sun Pharmaceuticals Related Developments
- 11.4 Actavis Generics
- 11.4.1 Actavis Generics Corporation Information
- 11.4.2 Actavis Generics Description and Business Overview
- 11.4.3 Actavis Generics Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Actavis Generics Imatinib Drug Products Offered
- 11.4.5 Actavis Generics Related Developments
- 11.5 Dr. Reddy's Laboratories
- 11.5.1 Dr. Reddy's Laboratories Corporation Information
- 11.5.2 Dr. Reddy's Laboratories Description and Business Overview
- 11.5.3 Dr. Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Dr. Reddy's Laboratories Imatinib Drug Products Offered
- 11.5.5 Dr. Reddy's Laboratories Related Developments
- 11.6 Teva Pharmaceutical Industries Ltd.
- 11.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information
- 11.6.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
- 11.6.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Products Offered
- 11.6.5 Teva Pharmaceutical Industries Ltd. Related Developments
- 11.7 Sanofi S.A.
- 11.7.1 Sanofi S.A. Corporation Information
- 11.7.2 Sanofi S.A. Description and Business Overview
- 11.7.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Sanofi S.A. Imatinib Drug Products Offered
- 11.7.5 Sanofi S.A. Related Developments
- 11.8 Cipla Inc.
- 11.8.1 Cipla Inc. Corporation Information
- 11.8.2 Cipla Inc. Description and Business Overview
- 11.8.3 Cipla Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Cipla Inc. Imatinib Drug Products Offered
- 11.8.5 Cipla Inc. Related Developments
- 11.9 Apotex Inc.
- 11.9.1 Apotex Inc. Corporation Information
- 11.9.2 Apotex Inc. Description and Business Overview
- 11.9.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Apotex Inc. Imatinib Drug Products Offered
- 11.9.5 Apotex Inc. Related Developments
- 11.10 Mylan Pharms Inc.
- 11.10.1 Mylan Pharms Inc. Corporation Information
- 11.10.2 Mylan Pharms Inc. Description and Business Overview
- 11.10.3 Mylan Pharms Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Mylan Pharms Inc. Imatinib Drug Products Offered
- 11.10.5 Mylan Pharms Inc. Related Developments
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description and Business Overview
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Imatinib Drug Products Offered
- 11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Imatinib Drug Market Estimates and Projections by Region
- 12.1.1 Global Imatinib Drug Sales Forecast by Regions 2021-2026
- 12.1.2 Global Imatinib Drug Revenue Forecast by Regions 2021-2026
- 12.2 North America Imatinib Drug Market Size Forecast (2021-2026)
- 12.2.1 North America: Imatinib Drug Sales Forecast (2021-2026)
- 12.2.2 North America: Imatinib Drug Revenue Forecast (2021-2026)
- 12.2.3 North America: Imatinib Drug Market Size Forecast by Country (2021-2026)
- 12.3 Europe Imatinib Drug Market Size Forecast (2021-2026)
- 12.3.1 Europe: Imatinib Drug Sales Forecast (2021-2026)
- 12.3.2 Europe: Imatinib Drug Revenue Forecast (2021-2026)
- 12.3.3 Europe: Imatinib Drug Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Imatinib Drug Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Imatinib Drug Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Imatinib Drug Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Imatinib Drug Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Imatinib Drug Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Imatinib Drug Sales Forecast (2021-2026)
- 12.5.2 Latin America: Imatinib Drug Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Imatinib Drug Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Imatinib Drug Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Imatinib Drug Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Imatinib Drug Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Imatinib Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Imatinib Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Imatinib Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Imatinib Drug. Industry analysis & Market Report on Imatinib Drug is a syndicated market report, published as Global Imatinib Drug Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Imatinib Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
